MDM2和DNMT1抑制剂通过p53-依赖和独立途径诱导神经母细胞瘤细胞死亡
Shyam Sundar Jaganathan1,2, Umamaheswari Natarajan1,2, Appu Rathinavelu1,2
1Rumbaugh-Goodwin Institute for Cancer Research, Nova Southeastern University, Ft. Lauderdale, FL, USA.
Epigenomics
|September 17, 2025
概括
这项研究表明,将MDM2抑制剂RG-7388与DNMT抑制剂CM-272和SGI-1027结合起来,可以有效地杀死神经母细胞瘤细胞. 这种组合疗法为侵袭性儿科癌症提供了一个有前途的新疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 神经母细胞瘤是一种高度侵略性的儿科癌症,治疗选择有限.
- 表观遗传修饰在神经母细胞瘤进展和治疗耐药性方面发挥着至关重要的作用.
研究的目的:
- 在神经母细胞瘤细胞中研究将MDM2抑制剂 (RG-7388) 与DNMT抑制剂 (CM-272,SGI-1027) 结合在一起的治疗潜力.
- 为了确定这种组合是否通过p21上调和亡诱导细胞死亡.
主要方法:
- 使用RG-7388,CM-272和SGI-1027.2治疗SK-N-SH和IMR-32神经母细胞瘤细胞.
- 评估细胞活力,-3/7激活和细胞亡标志物 (BAX,BCL-XL,PARP裂变).
- 基因表达分析使用qRT-PCR和Westernblotting进行p21.
主要成果:
- 联合药物治疗导致显著的神经母细胞瘤细胞死亡.
- 增加了p21和亲细胞灭绝的BAX的表达,降低了BCL-XL.
- RG-7388诱导了PARP裂变,表明通过p21依赖的途径激活了亡.
结论:
- 抑制MDM2和DNMT1通过p21驱动的机制促进神经母细胞瘤细胞的亡.
- 抑制DNMT1可能为p53突变的神经母细胞瘤提供治疗策略.
- 这种组合疗法显示出治疗侵袭性和耐治疗性神经母细胞瘤的潜力.
更多相关视频
相关概念视频
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
02:36DNA Damage can Stall the Cell Cycle
10.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.0K
02:36DNA Damage Can Stall the Cell Cycle
3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
01:31The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
01:23Negative Regulator Molecules
38.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.3K
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K